Alarming Global Rise in Adolescent Metabolic Dysfunction‐Associated Steatotic Liver Disease by 2030
Acta Paediatrica · 2026-03 · 115 (3) · 651-663
DOI: 10.1111/apa.70373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, online erschienen am 21.11.2025. Verfasst von Xiang Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Pancreatic Surgery, Ningbo No.2 Hospital, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Ningbo Clinical Research Center for Digestive System Tumors, Ningbo Top Medical and Health Research Program.
Abstract (Originalsprache)
Aim
This study forecasts the global burden of ultrasound‐diagnosed MASLD in adolescents (15–19 years) from 2020 to 2030, examining socioeconomic influences.
Methods
Using generalised additive models (GAM) and estimated annual percentage change (EAPC), age‐standardised incidence (ASIR), mortality (ASDR) and disability‐adjusted life years (DALYs) rates were projected. Regional analyses used the Socio‐Demographic Index (SDI), with regression models quantifying associations.
Results
Global ASIR is projected to rise significantly (EAPC: +1.46%), outpacing slower increases in DALYs (EAPC: +0.20%) and ASDR (EAPC: +0.18%). High‐income North America faces the steepest ASIR surge (EAPC: +2.52%), while Central/Eastern Europe and Central Asia are stable. By 2030, low‐SDI regions will have the highest median ASIR, with Turkmenistan predicted to have the world's highest (0.77 per 100 000). Striking disparities exist: higher SDI strongly correlates with elevated ASIR in Europe ( R 2 = 0.339), indicating lifestyle risks in affluent settings. Conversely, higher SDI correlates with reduced DALYs/ASDR elsewhere. Despite some declines in low‐SDI areas, high‐income North America and vulnerable low‐SDI regions (e.g., Turkmenistan) face escalating burdens.
Conclusions
Socioeconomic factors and lifestyle disparities drive divergent global adolescent MASLD trajectories. Without intervention, the burden will surge by 2030—particularly in high‐income North America and low‐SDI hotspots—demanding region‐specific policies to address metabolic health inequities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Pancreatic Surgery, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
ORCID-Profile: Xiang Li
Förderung
- Ningbo Clinical Research Center for Digestive System Tumors
- Ningbo Top Medical and Health Research Program
Zitieren
APA
Li, X., & Yu, H. (2026). Alarming Global Rise in Adolescent Metabolic Dysfunction‐Associated Steatotic Liver Disease by 2030. Acta Paediatrica, 115(3), 651-663. https://doi.org/10.1111/apa.70373
Vancouver
Li X, Yu H. Alarming Global Rise in Adolescent Metabolic Dysfunction‐Associated Steatotic Liver Disease by 2030. Acta Paediatrica. 2026;115(3):651-663. doi:10.1111/apa.70373
BibTeX
@article{Li2026,
author = {Li, Xiang and Yu, Hua},
title = {Alarming Global Rise in Adolescent Metabolic Dysfunction‐Associated Steatotic Liver Disease by 2030},
journal = {Acta Paediatrica},
year = {2026},
volume = {115},
number = {3},
pages = {651--663},
doi = {10.1111/apa.70373}
}
EUVIMED